XML 76 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements Level 3 (Tables)
9 Months Ended
Sep. 30, 2017
Fair Value Disclosures [Abstract]  
Assets and (liabilities) carried at fair value by hierarchy level
Assets and (Liabilities) Carried at Fair Value by Hierarchy Level as of September 30, 2017
 
Total
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
Significant
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets accounted for at fair value on a recurring basis
 
 
 
 
Fixed maturities, AFS
 
 
 
 
Asset-backed-securities ("ABS")
$
2,305

$

$
2,249

$
56

Collateralized debt obligations ("CDOs")
2,395


2,207

188

Commercial mortgage-backed securities ("CMBS")
5,120


5,027

93

Corporate
25,746


24,707

1,039

Foreign government/government agencies
1,365


1,332

33

Bonds of municipalities and political subdivisions ("municipal bonds")
12,435


12,349

86

Residential mortgage-backed securities ("RMBS")
4,205


2,255

1,950

U.S. Treasuries
4,098

338

3,760


Total fixed maturities
57,669

338

53,886

3,445

Fixed maturities, FVO
82


82


Equity securities, trading [1]
11

11



Equity securities, AFS
1,112

840

155

117

Derivative assets
 
 
 
 
Credit derivatives
8


8


Foreign exchange derivatives
(4
)

(4
)

Interest rate derivatives
2


2


Guaranteed minimum withdrawal benefit ("GMWB") hedging instruments
39


(1
)
40

Macro hedge program
158



158

Total derivative assets [2]
203


5

198

Short-term investments
3,756

1,922

1,834


Reinsurance recoverable for GMWB
51



51

Modified coinsurance reinsurance contracts
57


57


Separate account assets [3]
113,197

74,053

38,019

226

Total assets accounted for at fair value on a recurring basis
$
176,138

$
77,164

$
94,038

$
4,037

Liabilities accounted for at fair value on a recurring basis
 
 
 
 
Other policyholder funds and benefits payable
(GMWB embedded derivative)
$
(93
)
$

$

$
(93
)
Derivative liabilities
 
 
 
 
Credit derivatives
(3
)

(3
)

Equity derivatives
2



2

Foreign exchange derivatives
(270
)

(270
)

Interest rate derivatives
(479
)

(452
)
(27
)
GMWB hedging instruments
26


42

(16
)
Macro hedge program
8


(17
)
25

Total derivative liabilities [4]
(716
)

(700
)
(16
)
Contingent consideration [5]
(28
)


(28
)
Total liabilities accounted for at fair value on a recurring basis
$
(837
)
$

$
(700
)
$
(137
)

Assets and (Liabilities) Carried at Fair Value by Hierarchy Level as of December 31, 2016
 
Total
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
Significant
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets accounted for at fair value on a recurring basis
 
 
 
 
Fixed maturities, AFS
 
 
 
 
ABS
$
2,382

$

$
2,300

$
82

CDOs
1,916


1,502

414

CMBS
4,936


4,856

80

Corporate
25,666


24,586

1,080

Foreign government/government agencies
1,171


1,107

64

Municipal bonds
11,486


11,368

118

RMBS
4,767


2,795

1,972

U.S. Treasuries
3,679

620

3,059


Total fixed maturities
56,003

620

51,573

3,810

Fixed maturities, FVO
293

1

281

11

Equity securities, trading [1]
11

11



Equity securities, AFS
1,097

821

177

99

Derivative assets
 
 
 
 
Credit derivatives
17


17


Foreign exchange derivatives
27


27


Interest rate derivatives
(427
)

(427
)

GMWB hedging instruments
74


14

60

Macro hedge program
128


8

120

Other derivative contracts
1



1

Total derivative assets [2]
(180
)

(361
)
181

Short-term investments
3,244

878

2,366


Reinsurance recoverable for GMWB
73



73

Modified coinsurance reinsurance contracts
68


68


Separate account assets [3]
111,634

71,606

38,856

201

Total assets accounted for at fair value on a recurring basis
$
172,243

$
73,937

$
92,960

$
4,375

Liabilities accounted for at fair value on a recurring basis
 
 
 
 
Other policyholder funds and benefits payable
 
 
 
 
GMWB embedded derivative
$
(241
)
$

$

$
(241
)
Equity linked notes
(33
)


(33
)
Total other policyholder funds and benefits payable
(274
)


(274
)
Derivative liabilities
 
 
 
 
Credit derivatives
(13
)

(13
)

Equity derivatives
33


33


Foreign exchange derivatives
(237
)

(237
)

Interest rate derivatives
(542
)

(521
)
(21
)
GMWB hedging instruments
20


(1
)
21

Macro hedge program
50


3

47

Total derivative liabilities [4]
(689
)

(736
)
47

Contingent consideration [5]
(25
)


(25
)
Total liabilities accounted for at fair value on a recurring basis
$
(988
)
$

$
(736
)
$
(252
)
[1]
Included in other investments on the Condensed Consolidated Balance Sheets.
[2]
Includes OTC and OTC-cleared derivative instruments in a net positive fair value position after consideration of the accrued interest and impact of collateral posting requirements which may be imposed by agreements, clearing house rules and applicable law. See footnote 4 to this table for derivative liabilities.
[3]
Approximately $2.4 billion and $4.0 billion of investment sales receivable, as of September 30, 2017, and December 31, 2016, respectively, are excluded from this disclosure requirement because they are trade receivables in the ordinary course of business where the carrying amount approximates fair value. Included in the total fair value amount are $899 and $1.0 billion of investments, as of September 30, 2017 and December 31, 2016, respectively, for which the fair value is estimated using the net asset value per unit as a practical expedient which are excluded from the disclosure requirement to classify amounts in the fair value hierarchy.
[4]
Includes OTC and OTC-cleared derivative instruments in a net negative fair value position (derivative liability) after consideration of the accrued interest and impact of collateral posting requirements, which may be imposed by agreements, clearing house rules and applicable law.
[5]
For additional information see the Contingent Consideration section below.
Information about significant unobservable inputs used in Level 3 assets measured at fair value
Significant Unobservable Inputs for Level 3 - Freestanding Derivatives
 
Fair
Value
Predominant
Valuation 
Technique
Significant Unobservable Input
Minimum
Maximum
Impact of 
Increase in Input on 
Fair Value [1]
As of September 30, 2017
Interest rate derivatives
 
 
 
 
 
 
Interest rate swaps
$
(29
)
Discounted cash flows
Swap curve beyond 30 years
2
%
3
%
Decrease
Interest rate swaptions [2]
$
2

Option model
Interest rate volatility
2
%
3
%
Increase
GMWB hedging instruments
 
 
 
 
 
 
Equity variance swaps
$
(40
)
Option model
Equity volatility
12
%
19
%
Increase
Equity options
$
2

Option model
Equity volatility
27
%
27
%
Increase
Customized swaps
$
62

Discounted cash flows
Equity volatility
7
%
30
%
Increase
Macro hedge program [3]
 
 
 
 
 
 
Equity options
$
190

Option model
Equity volatility
15
%
30
%
Increase
As of December 31, 2016
Interest rate derivatives
 
 
 
 
 
 
Interest rate swaps
$
(29
)
Discounted cash flows
Swap curve beyond 30 years
3
%
3
%
Decrease
Interest rate swaptions [2]
$
8

Option model
Interest rate volatility
2
%
2
%
Increase
GMWB hedging instruments
 
 
 
 
 
 
Equity variance swaps
$
(36
)
Option model
Equity volatility
20
%
23
%
Increase
Equity options
$
17

Option model
Equity volatility
27
%
30
%
Increase
Customized swaps
$
100

Discounted cash flows
Equity volatility
12
%
30
%
Increase
Macro hedge program [3]
 
 
 
 
 
 
Equity options
$
188

Option model
Equity volatility
17
%
28
%
Increase
[1]
Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table. Changes are based on long positions, unless otherwise noted. Changes in fair value will be inversely impacted for short positions.
[2]
The swaptions presented are purchased options that have the right to enter into a pay-fixed swap.
[3]
Excludes derivatives for which the Company bases fair value on broker quotations
Significant Unobservable Inputs for Level 3 GMWB Embedded Customized and Reinsurance Derivatives
As of September 30, 2017
Significant Unobservable Input
Unobservable Inputs (Minimum)
Unobservable Inputs (Maximum)
Impact of Increase in Input
on Fair Value Measurement [1]
Withdrawal Utilization [2]
15%
100%
Increase
Withdrawal Rates [3]
—%
8%
Increase
Lapse Rates [4]
—%
40%
Decrease
Reset Elections [5]
20%
75%
Increase
Equity Volatility [6]
7%
30%
Increase
As of December 31, 2016
Significant Unobservable Input
Unobservable Inputs (Minimum)
Unobservable Inputs (Maximum)
Impact of Increase in Input
on Fair Value Measurement [1]
Withdrawal Utilization [2]
15%
100%
Increase
Withdrawal Rates [3]
—%
8%
Increase
Lapse Rates [4]
—%
40%
Decrease
Reset Elections [5]
20%
75%
Increase
Equity Volatility [6]
12%
30%
Increase
[1]
Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table.
[2]
Range represents assumed cumulative percentages of policyholders taking withdrawals.
[3]
Range represents assumed cumulative annual amount withdrawn by policyholders.
[4]
Range represents assumed annual percentages of full surrender of the underlying variable annuity contracts across all policy durations for in force business.
[5]
Range represents assumed cumulative percentages of policyholders that would elect to reset their guaranteed benefit base.
[6]
Range represents implied market volatilities for equity indices based on multiple pricing sources.
Roll-forward of Financial Instruments Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3)
Fair Value Roll-forwards for Financial Instruments Classified as Level 3 for the Three Months Ended September 30, 2017
 
Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
Fair value as of June 30, 2017
Included in net income [1] [2] [6]
Included in OCI [3]
Purchases
Settlements
Sales
Transfers into Level 3 [4]
Transfers out of Level 3 [4]
Fair value as of September 30, 2017
Assets
 
 
 
 
 
 
 
 
 
Fixed Maturities, AFS
 
 
 
 
 
 
 
 
 
 
ABS
$
96

$

$

$

$
(6
)
$
(6
)
$
7

$
(35
)
$
56

 
CDOs
339


(1
)
29




(179
)
188

 
CMBS
98

(1
)


(4
)



93

 
Corporate
1,136

(1
)
8

42

1

(40
)
19

(126
)
1,039

 
Foreign Govt./Govt. Agencies
29


1

9




(6
)
33

 
Municipal
86








86

 
RMBS
2,011


27

40

(119
)


(9
)
1,950

Total Fixed Maturities, AFS
3,795

(2
)
35

120

(128
)
(46
)
26

(355
)
3,445

Equity Securities, AFS
98


(4
)
23





117

Freestanding Derivatives, net [5]
 
 
 
 
 
 
 
 
 
 
Equity
2








2

 
Interest rate
(26
)
(1
)






(27
)
 
GMWB hedging instruments
40

(16
)






24

 
Macro hedge program
160

14


9





183

Total Freestanding Derivatives, net [5]
176

(3
)

9





182

Reinsurance Recoverable for GMWB
57

(9
)


3




51

Separate Accounts
192


3

37

(1
)
(2
)

(3
)
226

Total Assets
$
4,318

$
(14
)
$
34

$
189

$
(126
)
$
(48
)
$
26

$
(358
)
$
4,021

Liabilities
 
 
 
 
 
 
 
 
 
Other Policyholder Funds and Benefits Payable
 
 
 
 
 
 
 
 
 
 
Guaranteed Withdrawal Benefits
$
(134
)
$
58

$

$

$
(17
)
$

$

$

$
(93
)
 
Equity Linked Notes
(37
)



37





Total Other Policyholder Funds and Benefits Payable
(171
)
58



20




(93
)
Contingent Consideration [7]
(27
)
(1
)






(28
)
Total Liabilities
$
(198
)
$
57

$

$

$
20

$

$

$

$
(121
)
Fair Value Roll-forwards for Financial Instruments Classified as Level 3 for the Nine Months Ended September 30, 2017
 
Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
Fair value as of January 1, 2017
Included in net income [1] [2] [6]
Included in OCI [3]
Purchases
Settlements
Sales
Transfers into Level 3 [4]
Transfers out of Level 3 [4]
Fair value as of September 30, 2017
Assets
 
 
 
 
 
 
 
 
 
Fixed Maturities, AFS
 
 
 
 
 
 
 
 
 
 
ABS
$
82

$

$

$
70

$
(12
)
$
(6
)
$
33

$
(111
)
$
56

 
CDOs
414


(2
)
329

(208
)


(345
)
188

 
CMBS
80

(2
)
1

75

(10
)


(51
)
93

 
Corporate
1,080

(7
)
38

257

(39
)
(230
)
111

(171
)
1,039

 
Foreign Govt./Govt. Agencies
64


4

15

(2
)
(2
)

(46
)
33

 
Municipal
118

4

4



(40
)


86

 
RMBS
1,972


60

263

(329
)
(7
)

(9
)
1,950

Total Fixed Maturities, AFS
3,810

(5
)
105

1,009

(600
)
(285
)
144

(733
)
3,445

Fixed Maturities, FVO
11



4

(2
)
(13
)



Equity Securities, AFS
99


(9
)
27





117

Freestanding Derivatives, net [5]
 
 
 
 
 
 
 
 
 
 
Equity

(3
)

5





2

 
Interest rate
(21
)
(6
)






(27
)
 
GMWB hedging instruments
81

(57
)






24

 
Macro hedge program
167

7


9





183

 
Other contracts
1

(1
)







Total Freestanding Derivatives, net [5]
228

(60
)

14





182

Reinsurance Recoverable for GMWB
73

(33
)


11




51

Separate Accounts
201

3

5

148

(7
)
(45
)
10

(89
)
226

Total Assets
$
4,422

$
(95
)
$
101

$
1,202

$
(598
)
$
(343
)
$
154

$
(822
)
$
4,021

Liabilities
 
 
 
 
 
 
 
 
 
Other Policyholder Funds and Benefits Payable
 
 
 
 
 
 
 
 
 
 
Guaranteed Withdrawal Benefits
$
(241
)
$
197

$

$

$
(49
)
$

$

$

$
(93
)
 
Equity Linked Notes
(33
)
(4
)


37





Total Other Policyholder Funds and Benefits Payable
(274
)
193



(12
)



(93
)
Contingent Consideration [7]
(25
)
(3
)






(28
)
Total Liabilities
$
(299
)
$
190

$

$

$
(12
)
$

$

$

$
(121
)

Fair Value Roll-forwards for Financial Instruments Classified as Level 3 for the Three Months Ended September 30, 2016
 
Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
Fair value as of June 30, 2016
Included in net income [1] [2] [6]
Included in OCI [3]
Purchases
Settlements
Sales
Transfers into Level 3 [4]
Transfers out of Level 3 [4]
Fair value as of September 30, 2016
Assets
 
 
 
 
 
 
 
 
 
Fixed Maturities, AFS
 
 
 
 
 
 
 
 
 
 
ABS
$
41

$

$

$
18

$

$
(2
)
$

$
(26
)
$
31

 
CDOs
478


(3
)
1

(7
)



469

 
CMBS
79

(1
)

15

(6
)


(10
)
77

 
Corporate
1,136

(12
)
27

69

3

(52
)
115

(192
)
1,094

 
Foreign Govt./Govt. Agencies
72


2

9

(1
)
(8
)


74

 
Municipal
90


2

34





126

 
RMBS
1,873


15

253

(78
)
(8
)


2,055

Total Fixed Maturities, AFS
3,769

(13
)
43

399

(89
)
(70
)
115

(228
)
3,926

Fixed Maturities, FVO
6



5

(1
)
(1
)


9

Equity Securities, AFS
97

(1
)

4





100

Freestanding Derivatives, net [5]
 
 
 
 
 
 
 
 
 
 
Equity
1

(1
)







 
Interest rate
(32
)







(32
)
 
GMWB hedging instruments
165

(34
)






131

 
Macro hedge program
141

(32
)

63

(4
)



168

 
Other contracts
4

(2
)






2

Total Freestanding Derivatives, net [5]
279

(69
)

63

(4
)



269

Reinsurance Recoverable for GMWB
106

(12
)


4




98

Separate Accounts
171

1

(1
)
165

(3
)
(11
)
10

(7
)
325

Total Assets
$
4,428

$
(94
)
$
42

$
636

$
(93
)
$
(82
)
$
125

$
(235
)
$
4,727

Liabilities
 
 
 
 
 
 
 
 
 
Other Policyholder Funds and Benefits Payable
 
 
 
 
 
 
 
 
 
 
Guaranteed Withdrawal Benefits
$
(412
)
$
81

$

$

$
(17
)
$

$

$

$
(348
)
 
Equity Linked Notes
(28
)
(3
)






(31
)
Total Other Policyholder Funds and Benefits Payable
(440
)
78



(17
)



(379
)
Contingent Consideration [7]

23







23

Total Liabilities
$
(440
)
$
101

$

$

$
(17
)
$

$

$

$
(356
)

Fair Value Roll-forwards for Financial Instruments Classified as Level 3 for the Nine Months Ended September 30, 2016
 
Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
Fair value as of January 1, 2016
Included in net income [1] [2] [6]
Included in OCI [3]
Purchases
Settlements
Sales
Transfers into Level 3 [4]
Transfers out of Level 3 [4]
Fair value as of September 30, 2016
Assets
 
 
 
 
 
 
 
 
 
Fixed Maturities, AFS
 
 
 
 
 
 
 
 
 
 
ABS
$
37

$

$

$
18

$
(7
)
$
(2
)
$
18

$
(33
)
$
31

 
CDOs
541

(1
)
(5
)
1

(67
)



469

 
CMBS
150

(2
)
(3
)
65

(24
)
(3
)
1

(107
)
77

 
Corporate
854

(26
)
39

136

(52
)
(143
)
628

(342
)
1,094

 
Foreign Govt./Govt. Agencies
60

1

11

24

(3
)
(19
)


74

 
Municipal
49


7

54



16


126

 
RMBS
1,622


11

683

(236
)
(8
)
5

(22
)
2,055

Total Fixed Maturities, AFS
3,313

(28
)
60

981

(389
)
(175
)
668

(504
)
3,926

Fixed Maturities, FVO
16

(1
)

11

(3
)
(4
)

(10
)
9

Equity Securities, AFS
93

(1
)
7

6


(5
)


100

Freestanding Derivatives, net [5]
 
 
 
 
 
 
 
 
 
 
Equity

(16
)

16






 
Interest rate
(22
)
(10
)






(32
)
 
GMWB hedging instruments
135

(10
)





6

131

 
Macro hedge program
147

(36
)

63

(6
)



168

 
Other contracts
7

(5
)






2

Total Freestanding Derivatives, net [5]
267

(77
)

79

(6
)


6

269

Reinsurance Recoverable for GMWB
83

4



11




98

Separate Accounts
139

1

5

226

(12
)
(27
)
16

(23
)
325

Total Assets
$
3,911

$
(102
)
$
72

$
1,303

$
(399
)
$
(211
)
$
684

$
(531
)
$
4,727

Liabilities
 
 
 
 
 
 
 
 
 
Other Policyholder Funds and Benefits Payable
 
 
 
 
 
 
 
 
 
 
Guaranteed Withdrawal Benefits
$
(262
)
$
(36
)
$

$

$
(50
)
$

$

$

$
(348
)
 
Equity Linked Notes
(26
)
(5
)






(31
)
Total Other Policyholder Funds and Benefits Payable
(288
)
(41
)


(50
)



(379
)
Contingent Consideration [7]

23







23

Total Liabilities
$
(288
)
$
(18
)
$

$

$
(50
)
$

$

$

$
(356
)
[1]
The Company classifies realized and unrealized gains (losses) on GMWB reinsurance derivatives and GMWB embedded derivatives as unrealized gains (losses) for purposes of disclosure in this table because it is impracticable to track on a contract-by-contract basis the realized gains (losses) for these derivatives and embedded derivatives.
[2]
Amounts in these rows are generally reported in net realized capital gains (losses). The realized/unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on net income for the Company. All amounts are before income taxes and amortization of DAC.
[3]
All amounts are before income taxes and amortization of DAC.
[4]
Transfers in and/or (out) of Level 3 are primarily attributable to the availability of market observable information and the re-evaluation of the observability of pricing inputs.
[5]
Derivative instruments are reported in this table on a net basis for asset (liability) positions and reported in the Condensed Consolidated Balance Sheets in other investments and other liabilities.
[6]
Includes both market and non-market impacts in deriving realized and unrealized gains (losses).
[7]
For additional information, see the Contingent Consideration section of this Note 5 - Fair Value Measurements of Notes to Condensed Consolidated Financial Statements.

Changes in Unrealized Gains (Losses) Included in Net Income for Financial Instruments Classified as Level 3 Still Held at End of Period
 
 
Three months ended September 30,
Nine months ended September 30,
 
 
2017 [1] [2]
2016 [1] [2]
2017 [1] [2]
2016 [1] [2]
Assets
 
 
 
 
Fixed Maturities, AFS
 
 
 
 
 
CMBS
$

$

$
(1
)
$
(1
)
 
Corporate
(1
)
(13
)
(13
)
(14
)
Total Fixed Maturities, AFS
(1
)
(13
)
(14
)
(15
)
Fixed Maturities, FVO




Equity Securities, AFS

(1
)

(1
)
Freestanding Derivatives, net
 
 
 
 
 
Equity


(2
)

 
Interest rate
(1
)

(6
)
(10
)
 
GMWB hedging instruments
(16
)
(34
)
(57
)
(2
)
 
Macro hedge program
14

(34
)
8

(31
)
 
Other Contracts

(2
)

(5
)
Total Freestanding Derivatives, net
(3
)
(70
)
(57
)
(48
)
Reinsurance Recoverable for GMWB
(9
)
(12
)
(33
)
4

Separate Accounts


1


Total Assets
$
(13
)
$
(96
)
$
(103
)
$
(60
)
Liabilities
 
 
 
 
Other Policyholder Funds and Benefits Payable
 
 
 
 
 
Guaranteed Withdrawal Benefits
$
58

$
81

$
197

$
(36
)
 
Equity Linked Notes

(3
)
(4
)
(5
)
Total Other Policyholder Funds and Benefits Payable
58

78

193

(41
)
Contingent Consideration [3]
(1
)

(3
)

Total Liabilities
$
57

$
78

$
190

$
(41
)
[1]
All amounts in these rows are reported in net realized capital gains (losses). The realized/unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on net income for the Company. All amounts are before income taxes and amortization of DAC.
[2]
Amounts presented are for Level 3 only and therefore may not agree to other disclosures included herein.
[3]
For additional information, see the Contingent Consideration section of this Note 5 - Fair Value Measurements of Notes to Condensed Consolidated Financial Statements.
Fair value of assets and liabilities accounted for using the fair value option
Changes in Fair Value of Assets using Fair Value Option
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2017
2016
 
2017
2016
Assets
 
 
 
 
 
Fixed maturities, FVO
 
 
 
 
 
Corporate
$

$
1

 
$
(1
)
$
1

Foreign government


 

(1
)
RMBS
(1
)
3

 

8

Total fixed maturities, FVO
(1
)
4

 
(1
)
8

Equity, FVO


 
2

(34
)
Total realized capital gains (losses)
$
(1
)
$
4

 
$
1

$
(26
)
Fair Value, by Balance Sheet Grouping [Table Text Block]
Fair Value of Assets and Liabilities using the Fair Value Option
 
September 30, 2017
December 31, 2016
Assets
 
 
Fixed maturities, FVO
 
 
ABS
$

$
7

CDOs

3

CMBS

8

Corporate

40

U.S government

7

RMBS
82

228

Total fixed maturities, FVO
$
82

$
293



Financial Instruments Not Carried at Fair Value
Financial Assets and Liabilities Not Carried at Fair Value
 
Fair Value Hierarchy Level
Carrying Amount
Fair Value
September 30, 2017
Assets
 
 
 
Policy loans
Level 3
$
1,418

$
1,418

Mortgage loans
Level 3
$
6,058

$
6,215

Liabilities
 
 
 
Other policyholder funds and benefits payable [1]
Level 3
$
6,285

$
6,484

Senior notes [2]
Level 2
$
3,556

$
4,218

Junior subordinated debentures [2]
Level 2
$
1,582

$
1,724

Consumer notes [3] [4]
Level 3
$
9

$
9

Assumed investment contracts [3]
Level 3
$
517

$
540

December 31, 2016
Assets
 
 
 
Policy loans
Level 3
$
1,444

$
1,444

Mortgage loans
Level 3
$
5,697

$
5,721

Liabilities
 
 
 
Other policyholder funds and benefits payable [1]
Level 3
$
6,714

$
6,906

Senior notes [2]
Level 2
$
3,969

$
4,487

Junior subordinated debentures [2]
Level 2
$
1,083

$
1,246

Consumer notes [3] [4]
Level 3
$
20

$
20

Assumed investment contracts [3]
Level 3
$
487

$
526

[1]
Excludes guarantees on variable annuities, group accident and health and universal life insurance contracts, including corporate owned life insurance.
[2]
Included in long-term debt in the Condensed Consolidated Balance Sheets, except for current maturities, which are included in short-term debt.
[3]
Excludes amounts carried at fair value and included in preceding disclosures.
[4]
Included in other liabilities in the Condensed Consolidated Balance Sheets.